Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Flare phenomenon in prostate cancer: recent evidence on new drugs and next generation imaging.
Conteduca V, Poti G, Caroli P, Russi S, Brighi N, Lolli C, Schepisi G, Romeo A, Matteucci F, Paganelli G, Marchetti P, De Giorgi U. Conteduca V, et al. Among authors: poti g. Ther Adv Med Oncol. 2021 Feb 24;13:1758835920987654. doi: 10.1177/1758835920987654. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 33708265 Free PMC article. Review.
Primary Mucosal Melanoma: Clinical Experience from a Single Italian Center.
Falcone R, Verkhovskaia S, Di Pietro FR, Poti G, Samela T, Carbone ML, Morelli MF, Zappalà AR, di Rocco ZC, Morese R, Piesco G, Marchetti P, Failla CM, De Galitiis F. Falcone R, et al. Among authors: poti g. Curr Oncol. 2024 Jan 22;31(1):588-597. doi: 10.3390/curroncol31010042. Curr Oncol. 2024. PMID: 38275835 Free PMC article.
Combining liquid biopsy and functional imaging analysis in metastatic castration-resistant prostate cancer helps predict treatment outcome.
Conteduca V, Scarpi E, Caroli P, Lolli C, Gurioli G, Brighi N, Poti G, Farolfi A, Altavilla A, Schepisi G, Matteucci F, Paganelli G, De Giorgi U. Conteduca V, et al. Among authors: poti g. Mol Oncol. 2022 Jan;16(2):538-548. doi: 10.1002/1878-0261.13120. Epub 2021 Nov 9. Mol Oncol. 2022. PMID: 34657387 Free PMC article.
Immunotherapy and Its Development for Gynecological (Ovarian, Endometrial and Cervical) Tumors: From Immune Checkpoint Inhibitors to Chimeric Antigen Receptor (CAR)-T Cell Therapy.
Schepisi G, Casadei C, Toma I, Poti G, Iaia ML, Farolfi A, Conteduca V, Lolli C, Ravaglia G, Brighi N, Altavilla A, Martinelli G, De Giorgi U. Schepisi G, et al. Among authors: poti g. Cancers (Basel). 2021 Feb 17;13(4):840. doi: 10.3390/cancers13040840. Cancers (Basel). 2021. PMID: 33671294 Free PMC article. Review.